These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Differential expression of microRNA miR-150-5p in IgA nephropathy as a potential mediator and marker of disease progression. Pawluczyk IZA, Didangelos A, Barbour SJ, Er L, Becker JU, Martin R, Taylor S, Bhachu JS, Lyons EG, Jenkins RH, Fraser D, Molyneux K, Perales-Patón J, Saez-Rodriguez J, Barratt J. Kidney Int; 2021 May; 99(5):1127-1139. PubMed ID: 33417998 [Abstract] [Full Text] [Related]
10. Urinary Exosomal MicroRNAs as New Noninvasive Biomarkers of IgA Nephropathy. Li S, Hao H, Li R, Guo S. Tohoku J Exp Med; 2022 Mar; 256(3):215-223. PubMed ID: 35314529 [Abstract] [Full Text] [Related]
11. Clinical significance of urinary exosomal microRNAs in patients with IgA nephropathy. Yoon SY, Kim JS, Jung SW, Kim YG, Hwang HS, Moon JY, Lee SH, Seo JW, Seok J, Tae D, Jeong K. Sci Rep; 2023 Oct 11; 13(1):17201. PubMed ID: 37821628 [Abstract] [Full Text] [Related]
14. High Neutrophil-To-Lymphocyte Ratio Is an Independent Risk Factor for End Stage Renal Diseases in IgA Nephropathy. Wang S, Dong L, Pei G, Jiang Z, Qin A, Tan J, Tang Y, Qin W. Front Immunol; 2021 Oct 11; 12():700224. PubMed ID: 34456912 [Abstract] [Full Text] [Related]
15. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients. Chai L, Cai K, Wang K, Luo Q. J Clin Lab Anal; 2021 Jun 11; 35(6):e23774. PubMed ID: 33951240 [Abstract] [Full Text] [Related]